Capstone Investment Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.17M | Buy |
121,122
+42,875
| +55% | +$2.33M | 0.01% | 494 |
|
|
2026
Q1 | $4.91M | Buy |
78,247
+67,771
| +647% | +$5.42M | 0.01% | 425 |
|
|
2025
Q4 | $999K | Sell |
10,476
-18,891
| -64% | -$1.85M | ﹤0.01% | 864 |
|
|
2025
Q3 | $2.87M | Buy |
+29,367
| New | +$3.04M | 0.01% | 637 |
|
|
2024
Q4 | – | Sell |
-5
| Closed | -$440 | – | 1854 |
|
|
2024
Q3 | $419 | Buy |
+5
| New | +$394 | ﹤0.01% | 1876 |
|
|
2024
Q1 | – | Sell |
-1,246
| Closed | -$80.1K | – | 2350 |
|
|
2023
Q4 | $72K | Buy |
+1,246
| New | +$66.5K | ﹤0.01% | 1970 |
|
|
2023
Q2 | – | Sell |
-15
| Closed | -$783 | – | 1841 |
|
|
2023
Q1 | $750 | Buy |
+15
| New | +$707 | ﹤0.01% | 1512 |
|
|
2022
Q4 | – | Sell |
-10,836
| Closed | -$469K | – | 1528 |
|
|
2022
Q3 | $420K | Buy |
+10,836
| New | +$435K | ﹤0.01% | 1329 |
|
|
2021
Q1 | – | Sell |
-131,325
| Closed | -$4.97M | – | 1687 |
|
|
2020
Q4 | $4.72M | Buy |
131,325
+122,400
| +1,371% | +$4.41M | 0.02% | 609 |
|
|
2020
Q3 | $341K | Buy |
8,925
+8,416
| +1,653% | +$324K | ﹤0.01% | 1228 |
|
|
2020
Q2 | $18K | Sell |
509
-19,209
| -97% | -$692K | ﹤0.01% | 1301 |
|
|
2020
Q1 | $643K | Sell |
19,718
-17,756
| -47% | -$694K | 0.01% | 831 |
|
|
2019
Q4 | $1.7M | Buy |
37,474
+34,445
| +1,137% | +$1.44M | 0.01% | 882 |
|
|
2019
Q3 | $123K | Buy |
3,029
+2,839
| +1,494% | +$120K | ﹤0.01% | 1274 |
|
|
2019
Q2 | $8K | Buy |
+190
| New | +$7.31K | ﹤0.01% | 1372 |
|
|
2018
Q4 | – | Sell |
-1,175
| Closed | -$42.6K | – | 1246 |
|
|
2018
Q3 | $45K | Sell |
1,175
-402
| -25% | -$14K | ﹤0.01% | 1213 |
|
|
2018
Q2 | $52K | Buy |
+1,577
| New | +$47.6K | ﹤0.01% | 647 |
|
|
2018
Q1 | – | Sell |
-15,165
| Closed | -$375K | – | 362 |
|
|
2017
Q4 | $375K | Buy |
+15,165
| New | +$418K | 0.01% | 321 |
|
|
2017
Q2 | – | Sell |
-384,549
| Closed | -$9.56M | – | 654 |
|
|
2017
Q1 | $9.56M | Buy |
+384,549
| New | +$9.35M | 0.24% | 75 |
|
|
2016
Q4 | – | Sell |
-76,587
| Closed | -$1.82M | – | 932 |
|
|
2016
Q3 | $1.82M | Sell |
76,587
-2,275
| -3% | -$54.3K | 0.04% | 277 |
|
|
2016
Q2 | $1.84M | Buy |
+78,862
| New | +$1.71M | 0.04% | 249 |
|
|
2016
Q1 | – | Sell |
-41,328
| Closed | -$762K | – | 649 |
|
|
2015
Q4 | $762K | Buy |
+41,328
| New | +$741K | 0.02% | 283 |
|
Other funds holding BSX
Capstone Investment Advisors's BSX Position: Q2 2026 in Review
Capstone Investment Advisors increased its Boston Scientific (BSX) stake by 55% in Q2 2026, buying an estimated $2.33M and bringing the position to 121,122 shares worth $5.17M. The position accounts for 0.01% of the portfolio, ranked #494.
Capstone Investment Advisors first reported a position in BSX in Q4 2015 and has held it in 22 quarters since. The position peaked at $9.56M in Q1 2017. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Capstone Investment Advisors held 121,122 shares of Boston Scientific worth $5.17M as of Q2 2026.
- Capstone Investment Advisors bought 42,875 Boston Scientific shares in Q2 2026, an estimated $2.33M.
- Boston Scientific made up 0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #494 holding.
- Capstone Investment Advisors first reported a position in Boston Scientific in Q4 2015 and has held it in 22 quarters since.
- Capstone Investment Advisors's Boston Scientific position peaked at $9.56M in Q1 2017.
- 1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.